| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/30/2004 | EP0815125B1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES |
| 06/30/2004 | EP0686161B1 Novel human beta2 integrin alpha subunit |
| 06/30/2004 | EP0584167B1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
| 06/30/2004 | CN1509337A New polynucleotides and polypeptides of IFN alpha-17 gene |
| 06/30/2004 | CN1509293A Expression technology for proteins containing hybrid isotype antibody moiety |
| 06/30/2004 | CN1508251A Malignant malarial parasite msra-3 gene, protein product and use thereof |
| 06/30/2004 | CN1508250A Malignant malarial parasite msra-2 gene, protein product and use thereof |
| 06/30/2004 | CN1508249A Maiignant malarial parasite msra-1 gene, protein product and use thereof |
| 06/30/2004 | CN1508155A Anti CD52 monoclonal antibody, coding sequence and use thereof |
| 06/30/2004 | CN1508151A Gclq receptor, HIV-laplzo area jointed with same and relative peptide and target-directional antibody |
| 06/30/2004 | CN1507790A Protein powder for fodder, and preparing method and use thereof |
| 06/30/2004 | CN1155714C Antifungal proteins, DNA coding therefore, and hosts incorporating same |
| 06/30/2004 | CN1155710C Recombinant herpesvirus with the use of gB Gene promoter |
| 06/30/2004 | CN1155620C Thioether conjugates |
| 06/30/2004 | CN1155619C Anti-TPO monoclonal antibody |
| 06/30/2004 | CN1155616C Human protein with cancer cell growth promoting function and its coding sequence |
| 06/30/2004 | CN1155615C Human protein with cancer cell growth suppressing function and its coding sequence |
| 06/30/2004 | CN1155614C Human protein with cancer cell growth suppressing function and its coding sequence |
| 06/30/2004 | CN1155613C Human tumor associated gene in 1-zone 3-band 3-subband of short arm of human chromosome No. 17 and its coding protein |
| 06/30/2004 | CN1155408C Stable lyophilized pharmaceutical substance from monoclonal or polyclonal antibodies |
| 06/29/2004 | US6756491 Receptor polypeptide for use in the treatment of urogenital disorders and cushing's syndrome |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/29/2004 | US6756478 Polypeptide for use in diagnosis and treatment of infections |
| 06/29/2004 | US6756361 Overcoming antibiotic resistance |
| 06/29/2004 | US6756227 Used as prophylactic and/or therapeutic agents and polypeptides in medicine |
| 06/29/2004 | US6756213 Nucleic acid encoding retinoic acid receptor |
| 06/29/2004 | US6756211 Neutropohil inhibitors |
| 06/29/2004 | US6756201 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 06/29/2004 | US6756036 Methods for treating cancer using PSCA antibodies and fragments thereof |
| 06/29/2004 | US6756035 Inhibiting interaction of cell bearing mammalian chemokine receptor with ligand by contacting cell with antibody or antigen which binds extracellular loop of receptor |
| 06/29/2004 | CA2294476C Semaphorin receptors |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/24/2004 | WO2004053487A1 METHOD OF DIAGNOSIS,TREATMENT AND USEFUL AGENTS FOR CONDITIONS CHARACTERISED BY MODULATION IN THE LEVEL OF ACTIVIN βC |
| 06/24/2004 | WO2004053460A2 Carrier-ligand fusions and uses thereof |
| 06/24/2004 | WO2004053139A1 A method of antibody production |
| 06/24/2004 | WO2004053102A2 Antibodies to treat cancer |
| 06/24/2004 | WO2004053064A2 Engineered fab'fragment anti-tumor necrosis factor alpha in combination with disease modifying anti-rheumatic drugs |
| 06/24/2004 | WO2004053063A2 Molecular determinants of myeloma bone disease and uses thereof |
| 06/24/2004 | WO2004052933A2 Peptide oligomers for use as hiv vaccines |
| 06/24/2004 | WO2004052932A2 Antibody (“11c7”) anti nogo a and its pharmaceutical use |
| 06/24/2004 | WO2004052920A2 Conversion of apoptotic proteins |
| 06/24/2004 | WO2004052398A1 Inducing tolerance in primates |
| 06/24/2004 | WO2004052397A1 Methods of treatment of ulcerative colitis with anti-cd3 antibodies |
| 06/24/2004 | WO2004052396A1 Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies |
| 06/24/2004 | WO2004052293A2 Recombinant vaccine against flavivirus infection |
| 06/24/2004 | WO2004052278A2 Escape mutants of newcastle disease virus as marker vaccines |
| 06/24/2004 | WO2004052277A2 Anthrax antitoxins |
| 06/24/2004 | WO2004052276A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/24/2004 | WO2004052233A2 Canine rankl and methods for preparing and using the same |
| 06/24/2004 | WO2004052186A2 Expressed genes that define the osteoclast phenotype |
| 06/24/2004 | WO2004041862A3 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 06/24/2004 | WO2004033658A8 Recombinant catalytic polypeptides and their uses |
| 06/24/2004 | WO2004030607A3 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 06/24/2004 | WO2004029094B1 Monoclonal antibody specific for human mitochondrial adenylate kinase isozyme 3 |
| 06/24/2004 | WO2004025293A3 Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells |
| 06/24/2004 | WO2004017899A3 Mono-specific polyclonal antibodies and methods for detecting clostridium difficile toxin a |
| 06/24/2004 | WO2004013278A3 Expression vectors |
| 06/24/2004 | WO2003106478A3 ANTIBODIES THAT BIND alphaE INTEGRIN |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003076631A3 Genetic products differentially expressed in tumors and use thereof |
| 06/24/2004 | WO2003068800A3 Isolated peptides which bind to hla molecules and uses thereof |
| 06/24/2004 | WO2003057715A8 Novel ligand involved in the transmigration of leukocytes . |
| 06/24/2004 | WO2003047336A3 TRANSGENIC ANIMALS BEARING HUMAN Igμ LIGHT CHAIN GENES |
| 06/24/2004 | WO2003033666A3 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 06/24/2004 | WO2003018044A8 New drug |
| 06/24/2004 | WO2003008560A8 A novel g protein-coupled receptor, gave8 |
| 06/24/2004 | WO2002092758A9 Gastrokines and derived peptides including inhibitors |
| 06/24/2004 | WO2001066563A8 T1r taste receptors and genes encoding same |
| 06/24/2004 | US20040122209 Products for regulating the degradation of collagen and methods for identifying same |
| 06/24/2004 | US20040121972 Methylenetetrahydrofolate reductase inhibitors and uses thereof |
| 06/24/2004 | US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals |
| 06/24/2004 | US20040121419 Methods of secretory vimentin detection and modulation |
| 06/24/2004 | US20040121415 Monovalent antibody fragments |
| 06/24/2004 | US20040121405 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications |
| 06/24/2004 | US20040121400 Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine |
| 06/24/2004 | US20040121395 Sequence #115 as a target for identifying weight modulating compounds |
| 06/24/2004 | US20040121387 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/24/2004 | US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders |
| 06/24/2004 | US20040121370 Novel composition and methods for the treatment of immune related diseases |
| 06/24/2004 | US20040121345 Identification of a human n-terminal acetyltransferase gene |
| 06/24/2004 | US20040121326 Neuregulin-4; for treating or preventing a disease, condition or syndrome associated with disregulation of an endogenous protein affecting receptor activity |
| 06/24/2004 | US20040121317 HIV envelopolype peptides |
| 06/24/2004 | US20040120960 initial dosing of a therapeutically effective amount of an LFA-1 antagonist, followed by a subsequent intermittent dosing of a therapeutically effective amount of an LFA-1 antagonist |
| 06/24/2004 | US20040120959 administering to a subject with a laminin 5-secreting tumor an amount effective to inhibit tumor growth and/or metastasis of an antibody that binds to one or more epitopes of the laminin 5 gamma 2 chain |
| 06/24/2004 | US20040120958 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 06/24/2004 | US20040120957 Use of A33 antigens JAM-it |
| 06/24/2004 | US20040120953 Antagonists of HMG1 for treating inflammatory conditions |
| 06/24/2004 | US20040120952 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 06/24/2004 | US20040120951 Human-type anti-blood coagulation factor viii antibody |
| 06/24/2004 | US20040120950 Modulation of VEGF-C/VEGFR-3 interactions in the treatment of rheumatoid arthritis |
| 06/24/2004 | US20040120948 antibody or a functional fragment thereof that recognizes a human CD40 antigen present on the surface of human B cells, dendritic cells |
| 06/24/2004 | US20040120947 DR4 antibodies and uses thereof |
| 06/24/2004 | US20040120945 Cell surface molecule mediating cell adhesion and signal transmission |
| 06/24/2004 | US20040120944 efficacy of the antibody is increased by taking all lots of eggs produced by an avian over at least the first 30 weeks following immunization, wherein all lots of eggs contain antibodies produced in response to the immunization, and blending |
| 06/24/2004 | US20040120893 human monoclonal antibody fragment (Fab), cloned by phage display that binds specifically to oxidized forms of low density lipoproteins (OxLDL) and not native LDL; use of the antibody for methods of diagnosis and treatment of atherosclerosis |
| 06/24/2004 | DE10256900A1 Tumorspezifische Erkennungsmoleküle Tumor-specific recognition molecules |
| 06/24/2004 | CA2509539A1 Method of diagnosis,treatment and useful agents for conditions characterised by modulation in the level of activin .beta.c |
| 06/24/2004 | CA2509387A1 Peptide oligomers for use as hiv vaccines |
| 06/24/2004 | CA2508773A1 Canine rankl and methods for preparing and using the same |